Results 71 to 80 of about 37,459 (257)

The rejection that defies anti-rejection drugs. Chronic vascular rejection (allograft vasculopathy): The role of terminology and linguistic relativity [PDF]

open access: yesarXiv, 2023
Solid organ transplantation has by now become a common medical procedure. Owing to the introduction of new immunosuppressive drugs, the allograft loss due to acute rejection has been reduced significantly over time. Tragically, the number of donor organs lost due to allograft vasculopathy (AV), generally named chronic vascular rejection or chronic ...
arxiv  

Different behaviour of BK-virus infection in liver transplant recipients [PDF]

open access: yes, 2016
Polyomavirus BK (BKV) infects up to 90% of the general population. After primary infection, occurring early during childhood, a state of non-replicative infection is established in the reno-urinary tract, without complications for immunocompetent hosts ...
MITTERHOFER, Anna Paola   +3 more
core   +2 more sources

Adherence is associated with a favorable outcome after lung transplantation.

open access: yesPLoS ONE, 2019
Non-adherence to therapy is associated with impaired outcome in solid organ allograft recipients. Outcome data are limited after lung transplantation. In a single-center cohort study, adherence was assessed in 427 patients undergoing lung transplantation
Anna Bertram   +6 more
doaj   +1 more source

Acute fibrinous and organising pneumonia following lung transplantation is associated with severe allograft dysfunction and poor outcome: a case series

open access: yesPneumonia, 2015
  Acute fibrinous and organising pneumonia (AFOP) is a histopathologic variant of acute lung injury that has been associated with infection and inflammatory disorders and has been reported as a complication of lung transplantation.
Keith Meyer   +4 more
doaj   +1 more source

Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy

open access: yesFrontiers in Immunology, 2022
Lung transplantation remains as a primary treatment for end-stage lung diseases. Although remarkable improvement has been achieved due to the immunosuppressive protocols, long-term survival for lung transplant recipients (LTR) is still limited.
María Iglesias-Escudero   +14 more
doaj   +1 more source

Thoracic Ultrasound in Lung Transplantation—Insights in the Field

open access: yesLife, 2023
The use of thoracic ultrasound (TUS) is a novel and dynamic diagnostic and monitoring modality that has shown remarkable advances within the last decade, with several published papers investigating its role within the field of lung transplantation.
Hans Henrik Lawaetz Schultz   +1 more
doaj   +1 more source

Differences in chronic lung allograft dysfunction between deceased-donor lung transplantation and living-donor lobar lung transplantation

open access: hybridJournal of Thoracic and Cardiovascular Surgery
Satona Tanaka   +9 more
openalex   +2 more sources

Unraveling the Role of Allo-Antibodies and Transplant Injury. [PDF]

open access: yes, 2016
Alloimmunity driving rejection in the context of solid organ transplantation can be grossly divided into mechanisms predominantly driven by either T cell-mediated rejection (TCMR) and antibody-mediated rejection (ABMR), though the co-existence of both ...
Matsuda, Yoshiko, Sarwal, Minnie M
core   +5 more sources

Shared features of endothelial dysfunction between sepsis and its preceding risk factors (aging and chronic disease) [PDF]

open access: yes, 2018
Acute vascular endothelial dysfunction is a central event in the pathogenesis of sepsis,increasing vascular permeability, promoting activation of the coagulation cascade, tissue edema and compromising perfusion of vital organs. Aging and chronic diseases(hypertension,dyslipidaemia,diabetes mellitus,chronic kidney disease,cardiovascular disease ...
arxiv   +1 more source

MicroRNAs Implicated in Dysregulation of Gene Expression Following Human Lung Transplantation [PDF]

open access: yesTransl Respir Med. 2013; 1: 12, 2013
Lung transplantation remains the only viable treatment option for the majority of patients with advanced lung diseases. However, 5-year post-transplant survival rates remain low primarily secondary to chronic rejection. Novel insights from global gene expression profiles may provide molecular phenotypes and therapeutic targets to improve outcomes after
arxiv   +1 more source

Home - About - Disclaimer - Privacy